Clinical Significance of the Circulating Chemokines in Breast Carcinoma Patients

刘刚,张杰,吴炅,陆劲松,沈镇宙,邵志敏

DOI: https://doi.org/10.3969/j.issn.1007-3639.2003.04.004

2003-01-01

Abstract:Purpose: To investigate the plasma levels of chemokine IL-8, GM-CSF, RANTES and MCP-1 in patients with breast carcinoma and in healthy controls and to explore its clinical, pathologic and diagnostic significance. Methods: Enzyme linked immunosorbent assay ( ELISA) kits were used in 93 breast cancer patients and 20 health controls, and clinical significance was analysed. Results: The plasma levels of IL-8, RANTES and MCP-1 were significantly higher in the patients than inthe healthy controls, and plasma levels of IL-8, MCP-1 and RANTES were significantly higher in patients with stage HI disease than those in patients with stage I. For the predictive value of distant metastasis, the sensitivities of IL-8, GM-CSF, RANTES, MCP-1 were 88.6%, 28.6%, 71. 4% and 60.0% respectively, and the corresponding specificities were 82. 8%, 93. 1%, 60. 3% and 82. 8%. Significant correlations were found between IL-8, GM-CSF, RANTES and MCP-1. Overall survival of breast cacer patients subdivided by positive IL-8 and MCP-1 group were lower than the negative group. Conclusions: This study indicates that the increased plasma levels of IL-8, MCP-1, and RANTES, might be valuable predictive markers for identifying metastatic breast cancer patients, and high expression of IL-8, MCP-1 as predictive markers of poor prognosis also.